Yüklüyor......
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
HER2 is overexpressed in approximately 10%-20% of gastric and gastroesophageal junction carcinomas. In these types of cancer, accurate assessment of HER2 status is mandatory, for selecting patients who may benefit from targeted therapies with anti-HER2 drugs such as Trastuzumab. This manuscript focu...
Kaydedildi:
| Yayımlandı: | World J Gastroenterol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948273/ https://ncbi.nlm.nih.gov/pubmed/27468182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i26.5879 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|